Katie Kosko

DocwireNews

A new study has uncovered an association between overall survival (OS) and intratumoral Escherichia in patients with advanced non-small cell lung cancer (NSCLC) who are receiving single-agent immune checkpoint inhibition.The large clinical trial, published in the Journal of Clinical Oncology, included 958 patients with advanced NSCLC. Researchers, led by Arielle Elkrief, MD, of the Memorial Sloan Kettering Cancer Center, evaluated unmapped next-generation sequencing reads against a bacterial genome database to determine if intratumoral Escherichia is associated with outcomes in patients receiving immune checkpoint inhibitiors.&ldquo;Preclinically, intratumoral Escherichia is associated with a proinflammatory tumor microenvironment and decreased metastases,&rdquo; the researchers explained.Overall survival (OS) was the primary endpoint and assessed using univariable and multivariable analyses. An external independent cohort (n=772) was used to further validate the study findings.Common environmental contaminants were filtered using no-template controls (n=2378). In addition, the researchers also performed fluorescence in situ hybridization (FISH) and transcriptomic profiling for Escherichia.Study results showed that read mapping to intratumoral Escherichia was associated with an OS of 16 months in patients treated with single-agent immunotherapy compared with 11 months for those who received combination chemoimmunotherapy (P=.0065).The association with OS in the single-agent cohort remained statistically significant in a multivariable analysis that adjusted for prognostic features, such as PD-L1 expression (P = .023), according to the study authors.The association with improved OS in univariable and multivariable analyses of patients who received treatment with single-agent immune checkpoint inhibitor was confirmed by the analysis of the external validation cohort.&ldquo;Escherichia localization within tumor cells was supported by coregistration of FISH staining and serial hematoxylin and eosin sections,&rdquo; Dr. Elkrief and colleagues explained. &ldquo;Transcriptomic analysis correlated Escherichia-positive samples with expression signatures of immune cell infiltration.&rdquo;The study highlights the possibility of targeting the intratumoral microbiome to enhance efficacy of treatment with immune checkpoint inhibitors in NSCLC.Source: <a href="https://ascopubs.org/doi/abs/10.1200/JCO.23.01488" target="_blank" rel="noopener">Journal of Clinical Oncology</a>

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

How the Intratumoral Microbiome Affects Immunotherapy Efficacy in NSCLC

Non-Small Cell Lung Cancer

There is a link between survival and intratumoral Escherichia in patients with advanced non-small cell lung cancer who are receiving single-agent immune checkpoint inhibition. 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe